Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients

被引:45
作者
Barentsz, Jelle O. [1 ]
Futterer, Jurgen J. [1 ]
Takahashi, Satoru [1 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Radiol, Nijmegen, Netherlands
关键词
ultrasmall; superparamagnetic; lymph;
D O I
10.1016/j.ejrad.2007.06.025
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A macrophage-specific magnetic resonance (MR) contrast agent allows the detection of small and otherwise undetectable lymph node metastases in patients with prostate cancer. This has an important clinical impact, as the diagnosis will be more precise and less invasive to obtain. Subsequently, this will reduce morbidity and health care costs. However, thorough knowledge of sequence parameters and planes, lymph node anatomy, appearance of normal and abnormal nodes, is essential when using this technique. This will be elaborated in this review. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:369 / 372
页数:4
相关论文
共 15 条
[1]   Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - Initial clinical experience [J].
Bellin, MF ;
Roy, C ;
Kinkel, K ;
Thoumas, D ;
Zaim, S ;
Vanel, D ;
Tuchmann, C ;
Richard, F ;
Jacqmin, D ;
Delcourt, A ;
Challier, E ;
Lebret, T ;
Cluzel, P .
RADIOLOGY, 1998, 207 (03) :799-808
[2]   Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT [J].
Borley, NC ;
Fabrin, K ;
Sriprasad, S ;
Mondaini, N ;
Thompson, PM ;
Muir, GH ;
Poulsen, J .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2003, 37 (05) :382-386
[3]   Urinary bladder cancer: Preoperative nodal staging with ferumoxtran-10-enhanced MR imaging [J].
Deserno, WMLLG ;
Harisinghani, MG ;
Taupitz, M ;
Jager, GJ ;
Witjes, JA ;
Mulders, PF ;
van de Kaa, CAH ;
Kaufmann, D ;
Barentsz, JO .
RADIOLOGY, 2004, 233 (02) :449-456
[4]   Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy [J].
Flanigan, RC ;
McKay, TC ;
Olson, M ;
Shankey, TV ;
Pyle, J ;
Waters, WB .
UROLOGY, 1996, 48 (03) :428-432
[5]   MICROVASCULAR PERMEABILITY OF NORMAL AND NEOPLASTIC TISSUES [J].
GERLOWSKI, LE ;
JAIN, RK .
MICROVASCULAR RESEARCH, 1986, 31 (03) :288-305
[6]   Noninvasive detection of clinically occult lymph-node metastases in prostate cancer [J].
Harisinghani, MG ;
Barentsz, J ;
Hahn, PF ;
Deserno, WM ;
Tabatabaei, S ;
van de Kaa, CH ;
de la Rosette, J ;
Weissleder, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2491-U5
[7]   Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR imaging at 1.5 and 3.0 T:: Early experience [J].
Heesakkers, RAM ;
Fütterer, JJ ;
Hövels, AM ;
van den Bosch, HCM ;
Scheenen, TWJ ;
Hoogeveen, YL ;
Barentsz, JO .
RADIOLOGY, 2006, 239 (02) :481-487
[8]   Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[18F]-2-deoxy-D-glucose [J].
Heicappell, R ;
Müller-Mattheis, V ;
Reinhardt, M ;
Vosberg, H ;
Gerharz, CD ;
Müller-Gärtner, HW ;
Ackermann, R .
EUROPEAN UROLOGY, 1999, 36 (06) :582-587
[9]   Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared rapid gradient-echo sequence [J].
Jager, GJ ;
Barentsz, JO ;
Oosterhof, GO ;
Witjes, JA ;
Ruijs, SJH .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1996, 167 (06) :1503-1507
[10]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30